Clinical Ocular Toxicology. Drugs, Chemicals and Herbs

Copyright Page\r......Page 2
DEDICATION\r......Page 3
PREFACE......Page 4
CONTRIBUTORS......Page 5
INSTRUCTIONS TO USERS......Page 6
10) Do not disregard alternative approaches and recommendations of how to behave in daily life......Page 7
REFERENCES AND FURTHER READING......Page 13
Applying your own medication (Fraunfelder 1999)......Page 14
REFERENCES AND FURTHER READING......Page 19
Summary......Page 20
Acknowledgment......Page 25
The role of non-Invasive electrophysIology In drug testIng......Page 31
Visual electrophysIology In drug development......Page 36
REFERENCES AND FURTHER READING......Page 41
How to Report A Suspected Reaction......Page 43
References And Further Reading......Page 45
Clinical significance......Page 48
Systemic administration (oral or intravenous)......Page 49
REFERENCES AND FURTHER READING......Page 50
Systemic administration – secondary to the drug-induced death of the organism......Page 51
clinical significance......Page 52
Systemic administration......Page 53
REFERENCES AND FURTHER READING......Page 54
Systemic administration......Page 55
Systemic administration......Page 56
clinical significance......Page 57
REFERENCES AND FURTHER READING......Page 58
Recommendations for topical ocular chloramphenicol......Page 59
Systemic reactions from topical ocular medication......Page 60
Primary use......Page 61
clinical significance......Page 62
REFERENCES AND FURTHER READING......Page 63
REFERENCES AND FURTHER READING......Page 64
clinical significance......Page 65
REFERENCES AND FURTHER READING......Page 66
REFERENCES AND FURTHER READING......Page 67
clinical significance......Page 68
REFERENCES AND FURTHER READING......Page 69
Systemic administration......Page 70
clinical significance......Page 71
clinical significance......Page 72
clinical significance......Page 73
Systemic administration......Page 74
REFERENCES AND FURTHER READING......Page 75
clinical significance......Page 76
clinical significance......Page 77
REFERENCES AND FURTHER READING......Page 78
Systemic administration......Page 79
clinical significance......Page 80
clinical significance......Page 81
Primary use......Page 82
Systemic administration......Page 83
clinical significance......Page 84
Systemic administration......Page 85
REFERENCES AND FURTHER READING......Page 86
clinical significance......Page 87
clinical significance......Page 88
Systemic administration......Page 89
Systemic administration......Page 90
REFERENCES AND FURTHER READING......Page 91
Generic names: 1. Amfetamine; 2. dextroamfetamine sulfate (dexamphetamine); 3. methamfetamine hydrochloride.......Page 92
Primary use......Page 93
REFERENCES AND FURTHER READING......Page 94
Primary use......Page 95
clinical significance......Page 96
clinical significance......Page 97
Recommendations (Fraunfelder, Fraunfelder and Keates)......Page 98
Systemic administration......Page 99
REFERENCES AND FURTHER READING......Page 100
REFERENCES AND FURTHER READING......Page 101
REFERENCES AND FURTHER READING......Page 102
clinical significance......Page 103
Systemic administration......Page 104
Systemic administration......Page 105
clinical significance......Page 106
REFERENCES AND FURTHER READING......Page 107
REFERENCES AND FURTHER READING......Page 108
clinical significance......Page 109
clinical significance......Page 110
REFERENCES AND FURTHER READING......Page 111
REFERENCES AND FURTHER READING......Page 112
Systemic administration (Primarily excessive dosage or chronic use)......Page 113
Primary use......Page 114
Systemic administration......Page 115
REFERENCES AND FURTHER READING......Page 116
REFERENCES AND FURTHER READING......Page 117
clinical significance......Page 118
REFERENCES AND FURTHER READING......Page 119
clinical significance......Page 120
clinical significance......Page 121
clinical significance......Page 122
REFERENCES AND FURTHER READING......Page 123
Primary use......Page 124
Systemic administration......Page 125
REFERENCES AND FURTHER READING......Page 126
Systemic administration......Page 127
Generic name: Diacetylmorphine (diamorphine, heroin).......Page 128
Systemic administration......Page 129
Systemic administration......Page 130
REFERENCES AND FURTHER READING......Page 131
clinical significance......Page 132
clinical significance......Page 133
clinical significance......Page 134
Primary use......Page 135
REFERENCES AND FURTHER READING......Page 136
REFERENCES AND FURTHER READING......Page 137
Systemic administration – spiral, caudal, epidural, extradural injections......Page 138
clinical significance......Page 139
REFERENCES AND FURTHER READING......Page 140
Systemic administration......Page 141
Systemic administration......Page 142
REFERENCES AND FURTHER READING......Page 143
REFERENCES AND FURTHER READING......Page 144
REFERENCES AND FURTHER READING......Page 145
REFERENCES AND FURTHER READING......Page 146
REFERENCES AND FURTHER READING......Page 147
REFERENCES AND FURTHER READING......Page 148
REFERENCES AND FURTHER READING......Page 149
Inhalation administration......Page 150
REFERENCES AND FURTHER READING......Page 151
Clinical significance......Page 152
Systemic administration......Page 153
Clinical significance......Page 154
Systemic administration......Page 155
Systemic administration......Page 156
Systemic administration......Page 157
Local ophthalmic use or exposure......Page 158
Primary use......Page 159
Clinical significance......Page 160
Clinical significance......Page 161
Topical application......Page 162
Clinical significance......Page 163
REFERENCES AND FURTHER READING......Page 164
Clinical significance......Page 165
REFERENCES AND FURTHER READING......Page 166
Clinical significance......Page 167
REFERENCES AND FURTHER READING......Page 168
Local ophthalmic use or exposure......Page 169
REFERENCES AND FURTHER READING......Page 170
Clinical significance......Page 171
REFERENCES AND FURTHER READING......Page 172
Section 7 Hormones and agents affecting Hormonal mechanisms......Page 173
Intraocular injection......Page 174
REFERENCES AND FURTHER READING......Page 176
Systemic......Page 178
REFERENCES AND FURTHER READING......Page 179
REFERENCES AND FURTHER READING......Page 180
REFERENCES AND FURTHER READING......Page 181
REFERENCES AND FURTHER READING......Page 182
REFERENCES AND FURTHER READING......Page 183
REFERENCES AND FURTHER READING......Page 184
REFERENCES AND FURTHER READING......Page 185
Intracameral injection......Page 186
Intracrameral injections......Page 187
REFERENCES AND FURTHER READING......Page 188
Clinical significance......Page 189
Systemic administration......Page 190
REFERENCES AND FURTHER READING......Page 191
Systemic administration......Page 192
Systemic administration......Page 193
Systemic administration – oral......Page 194
REFERENCES AND FURTHER READING......Page 195
Clinical significance......Page 196
REFERENCES AND FURTHER READING......Page 197
REFERENCES AND FURTHER READING......Page 198
REFERENCES AND FURTHER READING......Page 199
REFERENCES AND FURTHER READING......Page 200
REFERENCES AND FURTHER READING......Page 201
REFERENCES AND FURTHER READING......Page 202
Local ophthalmic use or exposure – mitomycin......Page 203
REFERENCES AND FURTHER READING......Page 204
REFERENCES AND FURTHER READING......Page 205
Systemic administration – intracarotid injection......Page 206
REFERENCES AND FURTHER READING......Page 207
Clinical significance......Page 208
REFERENCES AND FURTHER READING......Page 210
Systemic administration......Page 211
REFERENCES AND FURTHER READING......Page 212
Systemic administration......Page 213
Injection into the eyelid (fluorouracil)......Page 214
REFERENCES AND FURTHER READING......Page 215
REFERENCES AND FURTHER READING......Page 216
Systemic administration (intramuscular, subcutaneous or intravenous injections)......Page 217
REFERENCES AND FURTHER READING......Page 218
Systemic administration......Page 219
Systemic administration......Page 220
Systemic administration......Page 221
Systemic administration......Page 222
clinical significance......Page 224
Inadvertent ocular exposure – vinblastine......Page 225
REFERENCES AND FURTHER READING......Page 226
REFERENCES AND FURTHER READING......Page 227
REFERENCES AND FURTHER READING......Page 228
REFERENCES AND FURTHER READING......Page 230
REFERENCES AND FURTHER READING......Page 231
REFERENCES AND FURTHER READING......Page 232
REFERENCES AND FURTHER READING......Page 233
REFERENCES AND FURTHER READING......Page 234
REFERENCES AND FURTHER READING......Page 235
REFERENCES AND FURTHER READING......Page 236
REFERENCES AND FURTHER READING......Page 238
REFERENCES AND FURTHER READING......Page 240
REFERENCES AND FURTHER READING......Page 241
REFERENCES AND FURTHER READING......Page 242
REFERENCES AND FURTHER READING......Page 243
REFERENCES AND FURTHER READING......Page 244
REFERENCES AND FURTHER READING......Page 245
REFERENCES AND FURTHER READING......Page 246
REFERENCES AND FURTHER READING......Page 247
REFERENCES AND FURTHER READING......Page 248
Section 13 DrugS uSeD in ophthalmology......Page 249
REFERNCES AND FURTHER READING......Page 250
REFERNCES AND FURTHER READING......Page 251
REFERNCES AND FURTHER READING......Page 252
REFERNCES AND FURTHER READING......Page 253
REFERNCES AND FURTHER READING......Page 255
REFERNCES AND FURTHER READING......Page 257
REFERNCES AND FURTHER READING......Page 259
REFERNCES AND FURTHER READING......Page 261
REFERNCES AND FURTHER READING......Page 262
REFERNCES AND FURTHER READING......Page 263
REFERNCES AND FURTHER READING......Page 264
REFERNCES AND FURTHER READING......Page 265
REFERNCES AND FURTHER READING......Page 266
REFERNCES AND FURTHER READING......Page 267
REFERNCES AND FURTHER READING......Page 269
REFERNCES AND FURTHER READING......Page 270
REFERNCES AND FURTHER READING......Page 271
REFERNCES AND FURTHER READING......Page 273
REFERNCES AND FURTHER READING......Page 274
REFERNCES AND FURTHER READING......Page 276
REFERNCES AND FURTHER READING......Page 277
REFERNCES AND FURTHER READING......Page 279
REFERNCES AND FURTHER READING......Page 280
REFERNCES AND FURTHER READING......Page 281
REFERNCES AND FURTHER READING......Page 283
REFERNCES AND FURTHER READING......Page 284
REFERNCES AND FURTHER READING......Page 285
REFERNCES AND FURTHER READING......Page 287
REFERNCES AND FURTHER READING......Page 288
REFERNCES AND FURTHER READING......Page 289
REFERNCES AND FURTHER READING......Page 291
Recommendations......Page 292
Clinical significance......Page 293
Systemic administration – chronic intoxication......Page 294
REFERENCES AND FURTHER READING......Page 295
Primary use......Page 296
Recommendations......Page 297
Clinical significance......Page 298
Primary use......Page 299
Recommendations......Page 300
Topical ocular exposure......Page 301
Clinical significance......Page 302
Clinical significance......Page 303
Topical Ocular Exposure......Page 304
Recommendations......Page 305
Systemic exposure – chronic effects......Page 306
Clinical significance......Page 307
Topical ocular exposure......Page 308
REFERENCES AND FURTHER READING......Page 309
Primary use......Page 310
Systemic administration......Page 311
Systemic administration......Page 312
Systemic administration......Page 313
Clinical significance......Page 314
REFERENCES AND FURTHER READING......Page 315
Index of Side Effects......Page 316
A......Page 317
B......Page 320
C......Page 321
D......Page 327
E......Page 328
G......Page 333
H......Page 334
I......Page 335
K......Page 337
L......Page 338
M......Page 340
O......Page 343
P......Page 344
R......Page 348
S......Page 350
T......Page 352
U......Page 353
V......Page 355
Subject index......Page 359
A......Page 360
C......Page 361
E......Page 363
G......Page 364
K......Page 365
M......Page 366
O......Page 367
P......Page 368
S......Page 369
T......Page 370
Z......Page 371